Aspiriant LLC’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,175	Closed	-$209K	–	252
2018 Q3	$209K	Sell	2,175 -116	-5%	-$11.1K	0.02%	222
2018 Q2	$218K	Buy	+2,291	New	+$218K	0.02%	235